NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Expression of PARP-1 in Multiple Sclerosis Patients
Expression of PARP-1 in Multiple Sclerosis Patients

NCT05196425

CompletedNA

Sponsor: Sohag University

Conditions: Multiple Sclerosis

Interventions: Blood sampling

Countries: Egypt

This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 2021 to the end of December 2021. The study protocol will be approved by the Scientific Research Ethical Committee, Faculty of Medicine, Sohag University.

Eligibility overview

Sex: ALL

Age: 20 Years to 45 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria

Exclusion Criteria:

* • Isolated optic neuritis.
Locations (1)
  • Sohag, Egypt